SVI researchers uncover a new DNA protection process in the nucleolus that protects one of the most fragile regions in the genome
SVI researchers have uncovered a previously unknown process that helps cells repair damage in one of the most active and vulnerable parts of their DNA.
New grant to advance mRNA vaccine for type 1 diabetes
SVI researchers have been awarded a Breakthrough T1D INSPIRE grant to advance the development of an innovative mRNA vaccine that could one day help prevent type 1 diabetes before it starts.
Fellowship fuels search for new ovarian cancer treatments
Thanks to the generosity of the 5point Foundation, SVI researcher Dr Ruofei Liu will continue searching for new solutions for treatment-resistant ovarian cancers as the 2026 recipient of the Christine Martin Fellowship.
A new approach to heart and kidney disease: Donor support powers Anny (Nan) Su
Thanks to philanthropic support, Anny (Nan) Su is creating tiny, lab-grown 3D models of heart and kidney tissue to uncover the mechanisms driving cardiorenal syndrome.
New discovery reveals promising pathway for treating obesity and diabetes
A new study from SVI’s Diabetes & Metabolic Disease Lab has revealed a promising new way that the body regulates weight and blood sugar, by focusing on how the brain controls hunger, energy use and metabolism.
Vale Dorothy Kunstadt
SVI honours the life of Dorothy Kunstadt (née Rubinstein), who passed away peacefully on May 1, 2026.
SVI expands with two new research laboratories
SVI is excited to announce the launch of two new laboratories, further strengthening the Institute's research capacity through new expertise in cardiometabolic disease, DNA repair and cancer biology.
Which pieces of DNA did we inherit from ancient human relatives?
Modern humans carry traces of DNA inherited from Neanderthals and Denisovans, our ancient human relatives. But exactly what did we inherit, and how has it shaped us?
The Aikenhead Centre for Medical Discovery (ACMD) officially opens
The Aikenhead Centre for Medical Discovery (ACMD), Australia’s first hospital-based medical discovery centre, officially opened on Wednesday 10 June, marking the culmination of more than two decades of planning, collaboration and investment in a new model for healthcare innovation.
New funding brings gene editing for bone marrow failure syndromes closer to the clinic
SVI has secured landmark funding to progress a gene editing program aimed at transforming treatment for rare bone marrow failure syndromes through the Medical Research Future Fund (MRFF) Stem Cell Therapies Mission.
Helping strengthen cardiac care in Timor-Leste
Associate Professor Elizabeth Paratz has led a new publication highlighting a landmark achievement for cardiovascular care in Timor-Leste: the establishment of the country's first Cardiac Society.
SVI researchers to advance device-encapsulated stem cell therapy for heart attack recovery
Associate Professor Shiang (Max) Lim and his collaborators have received new support from the Medical Research Future Fund (MRFF) to take an innovative stem cell therapy for heart attack recovery into early-stage clinical trials.
From decoding disease to redefining treatment: inside SVI’s 2026 Research Report
SVI Director Professor Tom Kay presented the 2026 SVI Research Report at our Annual General Meeting in May, marking a year where advances across the Institute continued to redefine the possibilities of medical research.
Tom Kay receives award for lifetime contribution to type 1 diabetes research
SVI Director Professor Tom Kay has received the Breakthrough T1D Luminary Award for his dedication to type 1 diabetes research.
Professor Fabienne Mackay appointed as new SVI Director
We’re delighted to announce the appointment of Professor Fabienne Mackay as SVI’s next Director, following an extensive national and international search.
Donor support backs bold ideas in dementia research
Dementia is one of the leading causes of death worldwide, yet current treatments cannot stop the disease. At SVI, Dr Emma van der Westhuizen is determined to tackle this challenge, thanks to the generosity of the Yulgilbar Foundation.
Discovery Fund Luncheon celebrates multimillion-dollar impact on medical research progress
The 2026 SVI Discovery Fund Luncheon, graciously hosted by Christine Tarascio AM and her family, brought together supporters, scientists and friends for an engaging afternoon celebrating the impact of philanthropy on medical research.
AI-based tool estimates breast cancer risk within next four years
An international team, including Associate Professor Davis McCarthy and colleagues, has developed a breast screening artificial intelligence (AI) tool that estimates a woman’s risk of developing breast cancer more accurately than current methods.
Ancient DNA reveals how human evolution still shapes our immune system
Researchers from SVI’s Human Genomics & Evolution Lab have helped uncover how DNA inherited from extinct human relatives continues to influence our biology today.
MECCA backs BRAIx to bring AI-powered breast cancer detection into screening programs across Australia
The world‑leading, Australian‑developed artificial intelligence program BRAIx, designed to make breast cancer screening more accurate, personalised and efficient, has been given a major boost via a philanthropic gift from Australia’s leading prestige beauty retailer MECCA.